AbbVie
ABBV
#25
Rank
โ‚น49.478 T
Marketcap
โ‚น28,000
Share price
1.41%
Change (1 day)
38.43%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2026 (TTM): โ‚น806.12 Billion

According to AbbVie's latest financial reports the company's current earnings are โ‚น64.38 Billion. In 2025 the company made an earning of โ‚น626.38 Billion, an increase over its 2024 earnings that were of โ‚น352.83 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น806.12 B28.7%
2025 โ‚น626.38 B77.53%
2024 โ‚น352.83 B-40.54%
2023 โ‚น593.43 B-53.62%
2022 โ‚น1.279 T3.76%
2021 โ‚น1.233 T282.25%
2020 โ‚น322.64 B-59.67%
2019 โ‚น800.04 B62.13%
2018 โ‚น493.45 B-32.74%
2017 โ‚น733.67 B-1.99%
2016 โ‚น748.58 B18.65%
2015 โ‚น630.94 B180.5%
2014 โ‚น224.93 B-55.57%
2013 โ‚น506.27 B-6.86%
2012 โ‚น543.58 B56.05%
2011 โ‚น348.32 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น655.81 B-20.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น3.189 T 286.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น976.75 B 18.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น96.03 B-88.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-โ‚น185.63 Billion-122.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น1.130 T 36.91%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น1.360 T 64.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น749.10 B-9.31%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
โ‚น77.69 B-90.59%๐Ÿ‡บ๐Ÿ‡ธ USA